Session IV: Novel Approaches for Mitigating the Development of Resistance


James Hughes, Emory University


Using Pre- and Probiotics to Modify Host-Environmental Factors to Promote Health and Mitigate Disease


Michiel Kleerebezem, Holland

Suzanne Cunningham-Rundles, Cornell University


Governmental Approaches to Regulating Pre- and Probiotics


Lorenzo Morelli, Istituto di Microbiologia UCSC—Italy

Julienne Vaillancourt, CBER, FDA



Session V: Challenges and Opportunities to Developing a New Paradigm to Replace the “War Metaphor”


Fredrick Sparling, University of North Carolina, Chapel Hill

2:15–4:00 With the backdrop of the previous days’ presentations and discussion, Forum members, panel discussants, and the audience will comment on the issues and next steps that they would identify as priority areas for consideration within industry, academia, public health organizations, and other government sectors. The discussion of priorities will summarize the issues surrounding emerging opportunities for more effective collaboration as well as the remaining research and programmatic needs. The confounding issues of the major obstacles to preparing an optimal response, particularly as it relates to the complexities of interaction between private industry, research and public health agencies, regulatory agencies, policy makers, academic researchers, and the public, will be explored with an eye toward innovative responses to such challenges.

Panel Discussants:


Joshua Lederberg, Rockefeller University

David Stahl, University of Washington



The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement